{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:12:15Z","timestamp":1794460335584,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>The International Society of Urological Pathology held a conference devoted to issues in testicular and penile pathology in Boston in March 2015, which included a presentation and discussion led by the testis microscopic features working group. This conference focused on controversies related to staging and reporting of testicular tumors and was preceded by an online survey of the International Society of Urological Pathology members. The survey results were used to initiate discussions, but decisions were made by expert consensus rather than voting. A number of recommendations emerged from the conference, including that lymphovascular invasion (LVI) should always be reported and no distinction need be made between lymphatic or blood invasion. If LVI is equivocal, then it should be regarded as negative to avoid triggering unnecessary therapy. LVI in the spermatic cord is considered as category pT2, not pT3, unless future studies provide contrary evidence. At the time of gross dissection, a block should be taken just superior to the epididymis to define the base of the spermatic cord, and direct invasion of tumor in this block indicates a category of pT3. Pagetoid involvement of the rete testis epithelium must be distinguished from rete testis stromal invasion, with only the latter being prognostically useful. Percentages of different tumor elements in mixed germ cell tumors should be reported. Although consensus was reached on many issues, there are still areas of practice that need further evidence on which to base firm recommendations.<\/jats:p>","DOI":"10.1097\/pas.0000000000000844","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T15:31:09Z","timestamp":1491060669000},"page":"e22-e32","source":"Crossref","is-referenced-by-count":82,"title":["Reporting and Staging of Testicular Germ Cell Tumors"],"prefix":"10.1097","volume":"41","author":[{"given":"Clare","family":"Verrill","sequence":"first","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Srigley","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Centre, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comp\u00e9rat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hopital Tenon, Assistance Publique \u2013 Hopitaux de Paris, Universit\u00e9 Pierre et Marie Curie, Paris VI, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Egevad","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cytology, Karolinska Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ulbright","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Centre, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Berney","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Pathology, John Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 european pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1200\/JCO.2014.56.8006","article-title":"Treatment options for stage I non seminoma","volume":"32","author":"Feldman","year":"2014","journal-title":"J Clin Oncol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/modpathol.2012.189","article-title":"Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors","volume":"26","author":"Yilmaz","year":"2013","journal-title":"Mod Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0022-5347(17)44988-3","article-title":"Nonseminomatous germ cell tumor of the testicle: does extensive staging of the primary tumor predict the likelihood of metastatic disease?","volume":"136","author":"Rodriguez","year":"1986","journal-title":"J Urol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.canep.2013.03.017","article-title":"Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age","volume":"37","author":"Stang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PAS.0b013e3182a2926e","article-title":"Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis","volume":"38","author":"Alvarado-Cabrero","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.critrevonc.2007.04.014","article-title":"A comprehensive systematic review of testicular germ cell tumor surveillance","volume":"64","author":"Groll","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/111.4.534","article-title":"Extratesticular extension of germ cell tumors preferentially occurs at the hilum","volume":"111","author":"Dry","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R16-20230922","first-page":"S29","article-title":"Extratesticular extension in germ cell tumors","volume":"suppl 1","author":"Yilmaz","year":"2008","journal-title":"Virchows Arch"},{"issue":"suppl 28","key":"R17-20230922","first-page":"269A","article-title":"Hilar invasion in testicular germ cell tumors: a potential understaging pitfall","volume":"28","author":"Yilmaz","year":"2015","journal-title":"Mod Pathol"},{"issue":"suppl","key":"R18-20230922","first-page":"4A","article-title":"The utility of sampling the testicular cord margin in germ cell tumors","volume":"24","author":"Berney","year":"2011","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0463.2006.apm_468.x","article-title":"Testicular germ cell tumors in Iceland: a nationwide clinicopathological study","volume":"114","author":"Agnarsson","year":"2006","journal-title":"APMIS"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Trial Group","volume":"21","author":"Albers","year":"2003","journal-title":"J Clin Oncol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1445-2197.1989.tb01480.x","article-title":"Prognostic indicators for failure of surveillance management of stage I non-seminomatous germ cell tumours","volume":"59","author":"Costello","year":"1989","journal-title":"Aust N Z J Surg"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I non-seminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.1988.6.9.1467","article-title":"Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology","volume":"6","author":"Fung","year":"1988","journal-title":"J Clin Oncol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0022-5347(17)44174-7","article-title":"Testicular cancer: prognostic implications of vascular invasion","volume":"137","author":"Hoeltl","year":"1987","journal-title":"J Urol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.1986.4.7.1031","article-title":"Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy","volume":"4","author":"Hoskin","year":"1986","journal-title":"J Clin Oncol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0090-4295(86)90329-8","article-title":"Predictors of recurrent clinical stage I nonseminomatous testicular cancer. A prospective clinicopathologic study","volume":"27","author":"Javadpour","year":"1986","journal-title":"Urology"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1990.8.3.509","article-title":"Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group","volume":"8","author":"Klepp","year":"1990","journal-title":"J Clin Oncol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/1097-0142(19851115)56:10<2492::AID-CNCR2820561027>3.0.CO;2-R","article-title":"Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Important in \u201csurveillance only\u201d protocols","volume":"56","author":"Moriyama","year":"1985","journal-title":"Cancer"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/1097-0142(19881015)62:8<1471::AID-CNCR2820620804>3.0.CO;2-A","article-title":"Results of adjuvant chemotherapy for low-stage nonseminomatous germ cell tumors of the testis with vascular invasion","volume":"62","author":"Sandeman","year":"1988","journal-title":"Cancer"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1200\/JCO.1992.10.4.564","article-title":"Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors","volume":"10","author":"Sturgeon","year":"1992","journal-title":"J Clin Oncol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.juro.2014.02.2569","article-title":"Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels","volume":"192","author":"Heinzelbecker","year":"2014","journal-title":"J Urol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1323::AID-CNCR15>3.0.CO;2-G","article-title":"Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease","volume":"85","author":"Fukuda","year":"1999","journal-title":"Cancer"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1442-2042.2010.02645.x","article-title":"Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients","volume":"17","author":"Kamba","year":"2010","journal-title":"Int J Urol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.1992.164","article-title":"Surveillance following orchidectomy for stage I testicular seminoma","volume":"65","author":"Horwich","year":"1992","journal-title":"Br J Cancer"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.juro.2011.05.070","article-title":"Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection","volume":"186","author":"Nicolai","year":"2011","journal-title":"J Urol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00185671","article-title":"Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis","volume":"12","author":"Donohue","year":"1994","journal-title":"World J Urol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.humpath.2013.05.004","article-title":"Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases","volume":"44","author":"Tarrant","year":"2013","journal-title":"Hum Pathol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.pas.0000128675.56664.f7","article-title":"Cystic trophoblastic tumor: a nonaggressive lesion in postchemotherapy resections of patients with testicular germ cell tumors","volume":"28","author":"Ulbright","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.urology.2013.04.082","article-title":"Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy","volume":"82","author":"Al-Ahmadie","year":"2013","journal-title":"Urology"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.juro.2006.10.068","article-title":"Does the presence of extranodal extension in pathological stage B1 nonseminatous germ cell tumor necessitate adjuvant chemotherapy?","volume":"177","author":"Beck","year":"2007","journal-title":"J Urol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/PAS.0000000000000233","article-title":"Best practice recommendations in the application of immunohistochemistry in testicular tumors: Report from the International Society of Urological Pathology Consensus Conference","volume":"38","author":"Ulbright","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<286::AID-GCC2>3.0.CO;2-6","article-title":"Chromosomal constitution of human spermatocytic seminomas: comparative genomic hybridization supported by conventional and interphase cytogenetics","volume":"23","author":"Rosenberg","year":"1998","journal-title":"Genes Chromosomes Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201706000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:31:15Z","timestamp":1695421875000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201706000-00001"}},"subtitle":["The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000844","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}